These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 11326946)
1. [Experimental studies on human lung cancer gene-therapy with HSV-TK/GCV system]. Sha H; Wang E; Bao G Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):265-7. PubMed ID: 11326946 [TBL] [Abstract][Full Text] [Related]
2. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter]. Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294 [TBL] [Abstract][Full Text] [Related]
3. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo. He XL; Guo XJ; Qian GS; He XH; Huang GJ; Chen WZ; Li SP Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study of dually targeting gene therapy system for pituitary adenomas]. Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489 [TBL] [Abstract][Full Text] [Related]
5. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter]. Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913 [TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice]. Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412 [TBL] [Abstract][Full Text] [Related]
7. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]. He J; Chen Y; Li H; Lu Y; Yan Y; Tan X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation]. Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658 [TBL] [Abstract][Full Text] [Related]
9. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549]. Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070 [TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834 [TBL] [Abstract][Full Text] [Related]
11. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]
12. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma]. Zhao Y; Zhang X; Hui H Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424 [TBL] [Abstract][Full Text] [Related]
13. [Suicide gene therapy for glioma using HSV-tk/GCV system]. Xu L; Ge K; Zheng Z Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915 [TBL] [Abstract][Full Text] [Related]
14. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951 [TBL] [Abstract][Full Text] [Related]
15. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Shibata MA; Morimoto J; Otsuki Y Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241 [TBL] [Abstract][Full Text] [Related]
16. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Su H; Lu R; Ding R; Kan YW Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975 [TBL] [Abstract][Full Text] [Related]
18. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775 [TBL] [Abstract][Full Text] [Related]
19. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714 [TBL] [Abstract][Full Text] [Related]